脂肪酶Adipsin(补体因子D)在甲状腺相关眼病发病机制中的作用
本研究检测甲状腺相关眼病(GO)与健康受试者眼眶脂肪组织中多种脂肪因子的mRNA表达,并在原代培养眼眶成纤维细胞中分析Adipsin(补体因子D)在IGF-1、CD40L刺激及脂肪分化下的表达;结果显示Adipsin在GO组织中显著升高,沉默Adipsin可抑制IGF-1诱导的炎性因子表达与脂肪分化,作者据此提出Adipsin可能是GO的潜在治疗靶点。
要点
- Adipsin基因在GO组织中表达显著升高,IGF-1、CD40L刺激及脂肪细胞分化后进一步升高。
- 沉默Adipsin可抑制IGF-1诱导的IL-6、IL-8、COX2、ICAM-1、CCL2基因表达及IL-6蛋白分泌。
- 沉默Adipsin还可减弱脂肪细胞分化,外源性重组Adipsin激活Akt、ERK、p-38与JNK通路。
核心结论
- 由眼眶成纤维细胞分泌的Adipsin可能在GO发病机制中发挥独特作用。
- 抑制Adipsin可减少眼眶成纤维细胞炎性细胞因子产生并减轻脂肪生成。
- 该体外研究为Adipsin作为GO潜在治疗靶点提供了依据。
研究设计与样本
- 在GO与健康受试者获取的脂肪组织中检测多种脂肪因子的mRNA表达。
- 在原代培养眼眶成纤维细胞中分析IGF-1、CD40L刺激及脂肪生成条件下的Adipsin蛋白产生。
- 以小干扰RNA(siRNA)阻断Adipsin,采用定量实时PCR、Western blot与ELISA评估其对炎性细胞因子产生和脂肪生成的影响,以油红O染色鉴定脂肪分化。
主要发现
- Adipsin基因表达在GO组织中显著升高。
- GO细胞中Adipsin在IGF-1和CD40L刺激后以及脂肪细胞分化后升高。
- 沉默Adipsin抑制IGF-1诱导的IL-6、IL-8、COX2、ICAM-1、CCL2基因表达及IL-6蛋白分泌。
- 沉默Adipsin减弱脂肪细胞分化。
- 外源性重组Adipsin处理激活Akt、ERK、p-38与JNK信号通路。
临床怎么用
- 作者在结论中认为Adipsin可能是GO的潜在治疗靶点,该结论基于体外研究。
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Graves' orbitopathy (GO) is an orbital manifestation of autoimmune Graves' disease, and orbital fibroblast is considered a target cell, producing pro-inflammatory cytokines and/or differentiating into adipocytes. Adipose tissue has been focused on as an endocrine and inflammatory organ secreting adipokines. We investigated the pathogenic role of a specific adipokine, adipsin, known as complement factor D in Graves' orbital fibroblasts. METHODS: The messenger RNA (mRNA) expression of multiple adipokines was investigated in adipose tissues harvested from GO and healthy subjects. Adipsin protein production was analyzed in primary cultured orbital fibroblasts under insulin growth factor (IGF)-1, CD40 ligand (CD40L) stimulation, and adipogenesis. The effect of blocking adipsin with small interfering RNA (siRNA) on pro-inflammatory cytokine production and adipogenesis was evaluated using quantitative real-time PCR, Western blot, and ELISA. Adipogenic differentiation was identified using Oil Red O staining. RESULTS: Adipsin gene expression was significantly elevated in GO tissue and increased after the stimulation of IGF-1 and CD40L, as well as adipocyte differentiation in GO cells. Silencing of adipsin suppressed IGF-1-induced IL-6, IL-8, COX2, ICAM-1, CCL2 gene expression, and IL-6 protein secretion. Adipsin suppression also attenuated adipocyte differentiation. Exogenous treatment of recombinant adipsin resulted in the activation of the Akt, ERK, p-38, and JNK signaling pathways. CONCLUSIONS: Adipsin, secreted by orbital fibroblasts, may play a distinct role in the pathogenesis of GO. Inhibition of adipsin ameliorated the production of pro-inflammatory cytokines and adipogenesis in orbital fibroblasts. Our study provides an in vitro basis suggesting adipsin as a potential therapeutic target for GO treatment.
引用
- Byeon HJ, Chae MK, Ko J, et al. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy. Invest Ophthalmol Vis Sci. 2023. PMID: 37555734. doi:10.1167/iovs.64.11.13
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。